Q2 EPS Forecast for Bioceres Crop Solutions Cut by Analyst

Bioceres Crop Solutions Corp. (NASDAQ:BIOXFree Report) – Analysts at Brookline Capital Management cut their Q2 2025 EPS estimates for shares of Bioceres Crop Solutions in a research report issued on Tuesday, November 12th. Brookline Capital Management analyst K. Dolliver now forecasts that the company will post earnings per share of $0.14 for the quarter, down from their previous forecast of $0.28. The consensus estimate for Bioceres Crop Solutions’ current full-year earnings is $0.33 per share. Brookline Capital Management also issued estimates for Bioceres Crop Solutions’ Q3 2025 earnings at $0.02 EPS and FY2025 earnings at $0.16 EPS.

Bioceres Crop Solutions (NASDAQ:BIOXGet Free Report) last issued its earnings results on Monday, November 11th. The company reported ($0.09) EPS for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.11). The company had revenue of $92.60 million for the quarter, compared to analysts’ expectations of $117.15 million. Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. During the same period last year, the business posted ($0.07) earnings per share.

BIOX has been the topic of a number of other research reports. Canaccord Genuity Group dropped their price target on Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating on the stock in a research report on Wednesday. Lake Street Capital dropped their target price on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating on the stock in a report on Wednesday, September 11th. Oppenheimer cut their target price on shares of Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating on the stock in a research report on Monday, October 21st. Finally, Roth Mkm reduced their price target on shares of Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating for the company in a report on Wednesday, September 11th. Four equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, Bioceres Crop Solutions presently has a consensus rating of “Buy” and an average price target of $12.13.

Get Our Latest Analysis on BIOX

Bioceres Crop Solutions Trading Down 3.9 %

BIOX opened at $6.17 on Friday. The company has a quick ratio of 0.86, a current ratio of 1.27 and a debt-to-equity ratio of 0.37. The stock’s fifty day moving average is $7.50 and its two-hundred day moving average is $9.75. The company has a market capitalization of $387.78 million, a P/E ratio of 308.65 and a beta of 0.49. Bioceres Crop Solutions has a 52 week low of $5.71 and a 52 week high of $14.05.

Institutional Investors Weigh In On Bioceres Crop Solutions

A number of hedge funds have recently made changes to their positions in BIOX. Oppenheimer & Co. Inc. bought a new position in Bioceres Crop Solutions in the first quarter worth about $139,000. Lazard Asset Management LLC purchased a new position in shares of Bioceres Crop Solutions in the 1st quarter worth approximately $212,000. Sumitomo Mitsui Trust Holdings Inc. bought a new position in shares of Bioceres Crop Solutions during the 2nd quarter worth approximately $472,000. Oak Family Advisors LLC raised its stake in shares of Bioceres Crop Solutions by 1.9% during the 2nd quarter. Oak Family Advisors LLC now owns 64,925 shares of the company’s stock worth $728,000 after acquiring an additional 1,208 shares in the last quarter. Finally, Ping Capital Management Inc. purchased a new stake in Bioceres Crop Solutions during the second quarter valued at approximately $448,000. 17.68% of the stock is currently owned by hedge funds and other institutional investors.

About Bioceres Crop Solutions

(Get Free Report)

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.

See Also

Earnings History and Estimates for Bioceres Crop Solutions (NASDAQ:BIOX)

Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.